News

Pharmabiz55m
Pharmacy institutions to be held liable for errors in documents submitted for scholarship: PCI
Pharmacy institutions to be held liable for errors in documents submitted for scholarship: PCI: Gireesh Babu, New Delhi ...
Pharmabiz55m
Indian pharma navigates compliance challenges to maintain global credibility by managing cost efficiency
Indian pharma navigates compliance challenges to maintain global credibility by managing cost efficiency: Nandita Vijayasimha, Bengaluru Saturday, May 24, 2025, 08:00 Hrs [IST] In ...
Pharmabiz55m
Indian pharma works to prioritize employee centricity with tech-driven HR practices
Indian pharma works to prioritize employee centricity with tech-driven HR practices: Nandita Vijayasimha, Bengaluru Saturday, May 24, 2025, 08:00 Hrs [IST] Indian pharma continues ...
Pharmabiz55m
India extends deadline for beta naphthol anti-dumping probe questionnaire amid stakeholder requests
India extends deadline for beta naphthol anti-dumping probe questionnaire amid stakeholder requests: Shardul Nautiyal, Mumbai Saturday, May 24, 2025, 08:00 Hrs [IST] The Directora ...
Pharmabiz55m
Ministry of Ayush adds nominee from Maharashtra to Advisory Council for ISM
The Union Ministry of Ayush has made amendments to its earlier notification to add a representative from Maharashtra to the Advisory Council for Indian Systems of Medicine, constituted in September, ...
Pharmabiz18h
Kilitch Drugs in Q4 clocks Rs. 58.62 crore revenues, net profit at Rs. 10.40 crore up by189.34%
Kilitch Drugs in Q4 clocks Rs. 58.62 crore revenues, net profit at Rs. 10.40 crore up by189.34%: Our Bureau, Bengaluru Friday, May 23, 2025, 14:15 Hrs [IST] Kilitch Drugs, a compa ...
Pharmabiz16h
Senti Bio gets additional $1.0 million tranche from CIRM grant for advancing clinical development of SENTI-202
Senti Bio gets additional $1.0 million tranche from CIRM grant for advancing clinical development of SENTI-202: South San Francisco, California Friday, May 23, 2025, 16:00 Hrs [IS ...
Pharmabiz19h
Emcure Pharma achieves robust Q4FY25 performance with 19% revenue growth and 63% profit after tax growth
Emcure Pharma achieves robust Q4FY25 performance with 19% revenue growth and 63% profit after tax growth: Our Bureau, Mumbai Friday, May 23, 2025, 13:45 Hrs [IST] Emcure Pharma ha ...
Pharmabiz19h
Pfizer and GITAM University empower rural women with employment through Pfizer autonomous teams programme
Pfizer and GITAM University empower rural women with employment through Pfizer autonomous teams programme: Our Bureau, Bengaluru Friday, May 23, 2025, 13:30 Hrs [IST] Pfizer Globa ...
Pharmabiz14h
Evaxion begins patient dosing in extension of phase 2 trial of AI-designed personalized cancer vaccine, EVX-01
Copenhagen, Denmark Friday, May 23, 2025, 18:00 Hrs [IST] ...
Pharmabiz18h
ANI Pharma initiates phase 4 trial of purified Cortrophin Gel to treat acute gout flares
ANI Pharma initiates phase 4 trial of purified Cortrophin Gel to treat acute gout flares: Princeton, New Jersey Friday, May 23, 2025, 14:00 Hrs [IST] ANI Pharmaceuticals, Inc., a ...
Pharmabiz15h
Sensodyne’s latest campaign highlights Sensitivity as a chronic oral health condition and educates consumers
Sensodyne’s latest campaign highlights Sensitivity as a chronic oral health condition and educates consumers: Our Bureau, Mumbai Friday, May 23, 2025, 17:30 Hrs [IST] Sensodyne, ...